发明名称 Vaccines comprising truncated HBC core protein plus saponin-based adjuvants
摘要 <p>Composition (A) comprises (i) one or more hepatitis B core antigens (HBcAg) containing amino acids 1 to x (x = 100-160),their fragments, variants of fragment variants; (ii) an adjuvant containing a saponin and/or saponin derivative; and (iii) optionally, one or more hepatitis B surface antigens (HBsAg), or their fragments, variants or variant fragments. ACTIVITY : Virucide; Hepatotropic; Antiinflammatory. Mice were immunized with a composition containing 5 mu g AbISCO-200 (RTM for a saponin composition) and 10 mu g HBcAg1-144+1 in 0.1 ml phosphate-buffered saline. The number of CD8 +> cells that expressed gamma -interferon was just over 100 per 10 5> such cells; compared with zero when the same antigen was administered without saponin. When the composition also contained 5 mu g HBsAg, the number of such cells was 170/10 5>. The composition also resulted in high levels of immunoglobulins G1 and G2b, indicating a Th1/Th2 response. MECHANISM OF ACTION : Vaccine.</p>
申请公布号 AU2006291430(A1) 申请公布日期 2007.03.22
申请号 AU20060291430 申请日期 2006.09.15
申请人 RHEIN BIOTECH GESELLSCHAFT FUR NEUE BIOTECHNOLOGISCHE PROZESSE UND PRODUKTE MBH 发明人 PASCALE BUCHMANN;ZBIGNIEW JANOWICZ;KARL MELBER
分类号 C07K14/02;A61K39/39;A61P31/04 主分类号 C07K14/02
代理机构 代理人
主权项
地址